Imaging focal and interstitial fibrosis with cardiovascular magnetic resonance in athletes with left ventricular hypertrophy: Implications for sporting participation

British Journal of Sports Medicine

Volumn 46, Issue SUPPL. 1, 2012, Pages

  Waterhouse, Deirdre F ^a   Ismail, Tevfik F ^b   Prasad, Sanjay K ^b   Wilson, Mathew G ^c   O'Hanlon, Rory ^a  

^a Blackrock Clinic Ireland   (Ireland)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ASPETAR ORTHOPAEDIC AND SPORTS MEDICINE HOSPITAL   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FIBROSIS; FORECASTING; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; MYOCARDITIS; PATHOLOGY; PHYSIOLOGY; REVIEW; SPORT; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; ATHLETES; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FIBROSIS; FORECASTING; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDITIS; MYOCARDIUM; SPORTS;

EID: 84869043912     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2012-091482     Document Type: Article

References (99)

1. La Gerche A, Taylor AJ, Prior DL. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. JACC Cardiovasc Imaging 2009;2:350-63.
2. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4. (Pubitemid 29010450)
3. Basavarajaiah S, Shah A, Sharma S. Sudden cardiac death in young athletes. Heart 2007;93:287-9. (Pubitemid 46579512)
4. de Noronha SV, Sharma S, Papadakis M, et al. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart 2009;95:1409-14.
5. Corrado D, Migliore F, Basso C, et al. Exercise and the risk of sudden cardiac death. Herz 2006;31:553-8. (Pubitemid 44579728)
6. Thompson PD, Franklin BA, Balady GJ, et al. American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology; American College of Sports Medicine. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115:2358-68. (Pubitemid 46685905)
7. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-75. (Pubitemid 37098275)
8. Maron BJ, Doerer JJ, Haas T, et al. Sudden deaths in young competitive athletes. Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-92.
9. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601. (Pubitemid 44515020)
10. Bille K, Figueiras D, Schamasch P, et al. Sudden cardiac death in athletes: the Lausanne recommendations. Eur J Cardiovasc Prev Rehabil 2006;13:859-75. (Pubitemid 44901147)
11. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012;14:13.
12. Papadakis M, Wilson MG, Ghani S, et al. Impact of ethnicity upon cardiovascular adaptation in competitive athletes: relevance to preparticipation screening. Br J Sports Med Published Online First:26 July 2012. doi:10.1136/bjsports-2012-091127.
13. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91:1596.
14. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes. Clinical, demo-graphic and pathologic profiles. J Am Med Assoc 1986;276:199-204.
15. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20. (Pubitemid 34250486)
16. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003;42:1687-713. (Pubitemid 37383745)
17. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.
18. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61. (Pubitemid 41170072)
19. Schelbert EB, Testa SM, Meier CG, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011;13:16.
20. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 1999;72:258-64. (Pubitemid 29154672)
21. Lima JAC, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004;44:1164-71. (Pubitemid 39208868)
22. Menghetti L, Basso C, Nava A, et al. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 1996;76:467.
23. Ichikawa Y, Sakuma H, Kitagawa K, et al. Evaluation of left ventricular volumes and ejection fraction using fast steady-state cine MR imaging: Comparison with left ventricular angiography. J Cardiovasc Magn Reson 2003;5:333-42. (Pubitemid 36569952)
24. Hoffmann R, von Bardeleben S, ten Cate F, et al. Assessment of systolic left ventricular function: A multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-16. (Pubitemid 40461103)
25. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9. (Pubitemid 28213624)
26. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8. (Pubitemid 38379570)
27. Croisille P, Revel D, Saeed M. Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. Eur Radiol 2006;16:1951-63. (Pubitemid 44193180)
28. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150-6.
29. Spiewak M, Malek LA, Misko J, et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 2010;74:e149-53.
30. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9. (Pubitemid 28213624)
31. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22. (Pubitemid 40779862)
32. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-90. (Pubitemid 44547428)
33. Messroghli DR, Radjenovic A, Kozerke S, et al. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-6. (Pubitemid 39295266)
34. Gai N, Turkbey EB, Nazarian S, et al. T1 mapping of the gadolinium-enhanced myocardium: Adjustment for factors affecting interpatient comparison. Magn Reson Med 2011;65:1407-15.
35. Thompson PD, Apple FS, Wu A. Marathoner's heart? Circulation 2006;114:2306-8. (Pubitemid 44847445)
36. Jerosh-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234-42.
37. Kehr E, Sono M, Chugh SS, et al. Gadolinium enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging 2008;24:61-8. (Pubitemid 350263105)
38. Wilson M, O'Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in life-long, veteran endurance athletes. J Appl Physiol 2011;110:1622-6.
39. Dall'armellina E, Piechnik SK, Ferreira VM, et al. Cardiovascular magnetic resonance by non contrast T1 mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012;14:15.
40. Whyte G, Sheppard M, George K, et al. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med 2008;42:304-5. (Pubitemid 351547696)
41. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837-49. (Pubitemid 40791557)
42. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000;15:264-72. (Pubitemid 30496722)
43. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43:2260-4. (Pubitemid 38757595)
44. Bishop JE, Greenbaum R, Gibson DG, et al. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol 1990;22:1157-65. (Pubitemid 20378828)
45. Herpel E, Pritsch M, Koch A, et al. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology 2006;48:736-47.
46. Mohlenkamp S, Lehmann N, Breuckmann F, et al. Running the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008;29:1903-10.
47. Wilson M, O'Hanlon R, Prasad S, et al. Biological markers of cardiac damage are not related to measures of cardiac systolic and diastolic function using cardiovascular magnetic resonance and echocardiography after an acute bout of prolonged endurance exercise. Br J Sports Med 2011;45:780-4.
48. Mousavi N, Czarnecki A, Kumar K, et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol 2009;103:1467-72.
49. Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. JAppl Physiol 2010;108:1148-53.
50. Dawson EA, Whyte GP, Black MA, et al. Changes in vascular and cardiac function after prolonged strenuous exercise in humans. J Appl Physiol 2008;105:1562-9.
51. Whyte GP. Clinical significance of cardiac damage and changes in function after exercise. Med Sci Sports Exerc 2008;40:1416-23.
52. Wu E, Judd RM, Vargas JD. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-8. (Pubitemid 32056497)
53. Moon JC, Mogensen J, Elliott PM, et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I. Heart 2005;91:1036-40. (Pubitemid 41060010)
54. Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009;53:284-91.
55. Maron BJ, Wolfson JK, Epstein SE, et al. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-57. (Pubitemid 16048006)
56. Moon JC. What is late gadolinium enhancement in hypertrophic cardiomyopathy?. Rev Esp Cardiol 2007;60:1-4. (Pubitemid 46359171)
57. Benito B, Gay-Jordi G, Serrano-Mollar A, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011;123:13-22.
58. Rowe WJ. Endurance exercise and injury to the heart. Sports Med 1993;16:73-9. (Pubitemid 23235889)
59. Virmani R, Robinowitz M, McAllister H. Nontraumatic death in joggers. A series of 30 patients at autopsy. Am J Med 1982;72:874-82. (Pubitemid 12086588)
60. Rowe WJ. A world record marathon runner with silent ischemia without coronary atherosclerosis. Chest 1991;99:1306-8.
61. Shirani J, Pick R, Roberts WC, et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000;35:36-44. (Pubitemid 30061256)
62. Lombardi R, Betocchi S, Losi MA, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy. Circulation 2003;108:1455-60. (Pubitemid 37176451)
63. Varnava AM, Elliott PM, Sharma S, et al. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 2000;84:476-82.
64. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64. (Pubitemid 36005903)
65. de Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart: 'zigzag' course of activation. Circulation 1993;88:915-26. (Pubitemid 23264006)
66. St John Sutton MG, Lie JT Anderson KR, et al. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 1980;44:433-43. (Pubitemid 11250375)
67. Gerdts E, Bjornstadt H, Toft S. Impact of diastolic doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). J Hyperten 2002;20:1223-9. (Pubitemid 34913644)
68. Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodelling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-25. (Pubitemid 44297115)
69. Petersen SE, Selvanayagam JB, Francis JM, et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005;7:551-8. (Pubitemid 40770332)
70. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
71. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
72. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7. (Pubitemid 36543376)
73. Ajmone Marsan N, Bax JJ. Cardiomyopathies: myocardial fibrosis assessed by CMR to predict events in HCM. Nat Rev Cardiol 2010;7:604-6.
74. Fluechter S, Kuschyk J, Wolpert C, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010;12:30.
75. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
76. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9. (Pubitemid 36859020)
77. Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 2009;54:242-9.
78. Latif S, Dixit S, Callans DJ. Ventricular arrhythmias in normal hearts. Cardiol Clin 2008;26:367-80. (Pubitemid 351758980)
79. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33. (Pubitemid 18035134)
80. Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J Appl Physiol 2010;108:1148-53.
81. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003;24:1473-80. (Pubitemid 37010576)
82. Luthi P, Zuber M, Ritter M, et al. Echocardiographic findings in former professional cyclists after long-term deconditioning of more than 30 years. Eur J Echocardiogr 2008;9:261-7. (Pubitemid 351665186)
83. La Gerche A, Robberecht C, Kuiperi C, et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart 2010;96:1268-74.
84. Ricci C, Longo R, Pagnan L, et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589-95. (Pubitemid 23006073)
85. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompactiona distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.
86. Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular noncompaction: a step towards classification as a distinct cardiomyopathy. Heart 2001;86:666-71. (Pubitemid 33086886)
87. Eitel I, Fuernau G, Walther C, et al. Delayed enhancement magnetic resonance imaging in isolated noncompaction of ventricular myocardium. Clin Res Cardiol 2008;97:277-9. (Pubitemid 351464529)
88. Dursun M, Agayev A, Nisli K, et al. MR imaging features of ventricular noncompaction: emphasis on distribution and pattern of fibrosis. Eur J Radiol 2010;74:147-51.
89. Nucifora G, Aquaro GD, Pingitore A, et al. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail 2011;13:170-6.
90. Lofiego C, Biagini E, Ferlito M, et al. Paradoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction. Am J Cardiol 2006;97:738-41. (Pubitemid 43255050)
91. Nemes A, Caliskan K, Geleijnse ML, et al. Reduced regional systolic function is not confined to the noncompacted segments in noncompaction cardiomyopathy. Int J Cardiol 2009;134:366-70.
92. Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008;29:89-95.
93. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6. (Pubitemid 26289246)
94. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22. (Pubitemid 40779862)
95. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1981-9.
96. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8. (Pubitemid 38379570)
97. Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol 2011;57:1291-6.
98. Wagner A, Schulz-Menger J, Dietz R, et al. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 2003;16:17-20. (Pubitemid 38325344)
99. Whyte GP, Sheppard M, George KP, et al. Arrhythmias and the athlete: mechanisms and clinical significance. Eur Heart J 2007;28:1399-401.